BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33822054)

  • 21. Variable Features of Juvenile Polyposis Syndrome With Gastric Involvement Among Patients With a Large Genomic Deletion of BMPR1A.
    Lieberman S; Beeri R; Walsh T; Schechter M; Keret D; Half E; Gulsuner S; Tomer A; Jacob H; Cohen S; Basel-Salmon L; Mansur M; Berger R; Katz LH; Golomb E; Peretz T; Levy Z; Kedar I; King MC; Levy-Lahad E; Goldberg Y
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00054. PubMed ID: 31259752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
    Cloughesy TF; Yoshimoto K; Nghiemphu P; Brown K; Dang J; Zhu S; Hsueh T; Chen Y; Wang W; Youngkin D; Liau L; Martin N; Becker D; Bergsneider M; Lai A; Green R; Oglesby T; Koleto M; Trent J; Horvath S; Mischel PS; Mellinghoff IK; Sawyers CL
    PLoS Med; 2008 Jan; 5(1):e8. PubMed ID: 18215105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Histologic Overlap and Distinction Among Various Hamartomatous Polyposis Syndromes.
    Gilad O; Rosner G; Fliss-Isakov N; Aharon-Kaspi S; Strul H; Gluck N; Kariv R
    Clin Transl Gastroenterol; 2019 May; 10(5):1-9. PubMed ID: 31107726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial deletion of 10q23.1 and confirmation of three 10qdel syndromes.
    Singh S; Aftimos S; George A; Love DR
    Singapore Med J; 2011 Jul; 52(7):e143-6. PubMed ID: 21808946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis.
    van Hattem WA; Brosens LA; de Leng WW; Morsink FH; Lens S; Carvalho R; Giardiello FM; Offerhaus GJ
    Gut; 2008 May; 57(5):623-7. PubMed ID: 18178612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy.
    Salviati L; Patricelli M; Guariso G; Sturniolo GC; Alaggio R; Bernardi F; Zuffardi O; Tenconi R
    Am J Hum Genet; 2006 Sep; 79(3):593-6; author reply 596-7. PubMed ID: 16909400
    [No Abstract]   [Full Text] [Related]  

  • 27. Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer.
    Marsh Durban V; Jansen M; Davies EJ; Morsink FH; Offerhaus GJ; Clarke AR
    Am J Pathol; 2014 Jan; 184(1):86-91. PubMed ID: 24200851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review.
    Gao XH; Li J; Zhao ZY; Xu XD; Du YQ; Yan HL; Liu LJ; Bai CG; Zhang W
    BMC Gastroenterol; 2020 Jun; 20(1):167. PubMed ID: 32487124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Looking for the hidden mutation: Bannayan-Riley-Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A.
    Golas MM; Auber B; Ripperger T; Pabst B; Schmidt G; Morlot M; Diebold U; Steinemann D; Schlegelberger B; Morlot S
    Am J Med Genet A; 2019 Jul; 179(7):1383-1389. PubMed ID: 31062505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial juvenile polyposis syndrome with a de novo germline missense variant in BMPR1A gene: a case report.
    Liu Q; Liu M; Liu T; Yu Y
    BMC Med Genet; 2020 Oct; 21(1):196. PubMed ID: 33032550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic alterations in juvenile polyps from BMPR1A and SMAD4 mutation carriers.
    Blatter RH; Plasilova M; Wenzel F; Gokaslan ST; Terracciano L; Ashfaq R; Heinimann K
    Genes Chromosomes Cancer; 2015 Sep; 54(9):575-82. PubMed ID: 26171675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis.
    Calva-Cerqueira D; Dahdaleh FS; Woodfield G; Chinnathambi S; Nagy PL; Larsen-Haidle J; Weigel RJ; Howe JR
    Hum Mol Genet; 2010 Dec; 19(23):4654-62. PubMed ID: 20843829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
    Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
    Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse Hamartomatous Change in the Gallbladder of a Patient With Deletion Involving PTEN and BMPR1A Genes.
    Chezar K; Cass DL; Kurowski JA; Radhakrishnan K; Eng C; Zhang X
    Am J Gastroenterol; 2023 Nov; 118(11):1921. PubMed ID: 37252796
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes].
    Delnatte C; Sanlaville D; Mougenot JF; Stoppa-Lyonnet D
    Med Sci (Paris); 2006 Nov; 22(11):912-3. PubMed ID: 17101085
    [No Abstract]   [Full Text] [Related]  

  • 37. BMPR1A mutation-positive juvenile polyposis syndrome and atrial septal defect: coincidence or association?
    Harris RE; Russell RK
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31229977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.
    Ngeow J; Heald B; Rybicki LA; Orloff MS; Chen JL; Liu X; Yerian L; Willis J; Lehtonen HJ; Lehtonen R; Mester JL; Moline J; Burke CA; Church J; Aaltonen LA; Eng C
    Gastroenterology; 2013 Jun; 144(7):1402-9, 1409.e1-5. PubMed ID: 23399955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiorgan Transplantation as a Viable Treatment Option in Infantile Juvenile Polyposis Syndrome.
    Chandan OC; Reyes-Santiago E; Vargas L; Mercer D; Grant W; Langnas A; Quiros-Tejeira RE; Vo H
    J Pediatr Gastroenterol Nutr; 2019 May; 68(5):e86-e87. PubMed ID: 30134330
    [No Abstract]   [Full Text] [Related]  

  • 40. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.
    Li T; Yang Y; Li X; Xu C; Meng L
    Mol Cell Biochem; 2012 Feb; 361(1-2):19-29. PubMed ID: 21952748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.